18 March 2021 : Clinical Research
Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial
Shuai Fu1ABC, Haitian Xie1DEF, Yilei Zhong12BCD, Qi Xu1D, Liqiong Zhu1B, Hanjie Mo1B, Jianping Zhang1AG, Yinglin Liu1CF, Hui Chen1AG, Yonghong Zhong2AD*, Jianping Tan1ADDOI: 10.12659/MSM.929743
Med Sci Monit 2021; 27:e929743
Table 3 Indicators of infection 1 week after treatment. Categorical data are shown as a frequency (percentage) and continuous data are shown as mean±SD. The t test was used for analyzing quantitative data, and the χ2 test was used for analyzing categorical data. P<0.05 was considered statistically significant.
| Items | Control group (n=22) | Research group (n=30) | P | OR (95%CI) |
|---|---|---|---|---|
| White blood cell counts (×10/L) | 10.92±2.44 | 10.44±2.10 | 0.459 | – |
| Neutrophils (%) | 72.19±7.06 | 78.32±4.26 | 0.001* | – |
| C-reactive protein (mg/L) | 7.76±4.98 | 18.41±14.81 | 0.001* | – |
| Leucorrhea cleanliness | 2.05±0.52 | 2.09±0.38 | 0.681 | – |
| Monilial infection (cases) | 1 | 2 | 0.412 | 1.50 (0.13–17.67) |
| Mycoplasma infection (cases) | 3 | 4 | 0.877 | 0.97 (0.20–4.87) |
| * | ||||